Gene-Edited Wheat Yields 41% More. Regulators Banned It in 23 Countries.

A gene-edited variety of wheat developed at the International Maize and Wheat Improvement Center in Mexico yields 41 percent more grain under drought conditions than conventional varieties, according to field trials published in Nature Plants in March 2026. The modification, which uses CRISPR-Cas9 to enhance the plant's water-use efficiency, could increase food security for an estimated 690 million people living in water-scarce regions. Yet regulatory frameworks in 23 countries—including the entire European Union, India, and several East African nations where drought is most severe—classify the technology as genetically modified organisms subject to approval processes that have taken an average of 8.7 years to complete, when they complete at all.

For Samuel Wanjiru, a 52-year-old smallholder farmer in Machakos County, Kenya, the distinction between gene editing and genetic modification is academic. His three-hectare farm has experienced five consecutive years of below-average rainfall. His 2025 wheat harvest yielded 1.2 tonnes per hectare, down from 2.8 tonnes in 2020. "I have heard there are new seeds that can grow with less water," he said in an interview in April. "But nobody tells us when they will come, or if they will come." Kenya's National Biosafety Authority has been reviewing applications for gene-edited crops since 2021. None have been approved.

The gap between scientific capability and regulatory permission has widened dramatically in the past five years. Researchers have used CRISPR and other gene-editing tools to develop varieties of wheat, rice, maize, cassava, and sorghum that are drought-tolerant, disease-resistant, or nutritionally enhanced. A CRISPR-edited rice variety developed at the Chinese Academy of Agricultural Sciences shows 38 percent resistance to bacterial blight, which destroys an estimated 60 million tonnes of rice annually. A biofortified cassava developed in Nigeria contains 250 percent more beta-carotene than conventional varieties, addressing vitamin A deficiency that causes blindness in 250,000 children each year, according to the World Health Organization.

Yet only seven countries—the United States, Argentina, Brazil, Japan, Australia, Colombia, and Paraguay—have created regulatory pathways that distinguish gene editing from older forms of genetic modification. The distinction is scientifically significant: gene editing typically involves precise changes to an organism's existing DNA without introducing foreign genetic material, while genetic modification often involves inserting genes from other species. The European Court of Justice ruled in 2018 that gene-edited organisms must be regulated as GMOs, a decision that environmental groups celebrated and agricultural scientists called scientifically incoherent.

The Patent Barrier

Even in jurisdictions that permit gene-edited crops, intellectual property disputes have slowed their deployment. The Broad Institute and the University of California have been litigating ownership of CRISPR patents since 2014. As of April 2026, more than 11,000 patents related to CRISPR technology have been filed globally, according to the WIPO Patent Database. The majority are held by corporations and research institutions in high-income countries. Licensing fees for CRISPR applications in agriculture range from $150,000 to $2.8 million per crop variety, costs that public research institutions in low-income countries cannot afford.

Dr. Kanwarpal Dhugga, who led crop biotechnology research at the Donald Danforth Plant Science Center in St. Louis before retiring in 2024, described the patent landscape as "a thicket that strangles innovation where it is most needed." His team developed a drought-tolerant sorghum variety using CRISPR that showed 47 percent higher yields in water-stressed environments during trials in Mali and Senegal between 2022 and 2024. Deployment has stalled over questions about which institution holds the necessary patents. "We can edit the genome of a staple crop to save lives," Dhugga said. "But we cannot edit the legal system that prevents us from distributing it."

The International Food Policy Research Institute estimated in a January 2026 report that gene-edited crop varieties could increase global food production by 12 to 18 percent by 2040 if regulatory and intellectual property barriers were removed. The same report found that under current regulatory frameworks, adoption would be limited to high-income countries and a handful of middle-income nations, with minimal impact on the 47 countries classified as low-income food-deficit countries by the Food and Agriculture Organization.

The Politics of Perception

Public opposition to genetically modified organisms, rooted in campaigns that began in the 1990s, has proven difficult to overcome even when the science has changed. A 2024 Eurobarometer survey found that 68 percent of European Union citizens believe gene-edited foods should be regulated as strictly as GMOs, despite educational campaigns emphasizing the technical differences. Environmental organizations including Greenpeace and Friends of the Earth have opposed regulatory exemptions for gene editing, arguing that insufficient long-term safety data exists and that the technology will consolidate corporate control over food systems.

The European Commission proposed new regulations in July 2023 that would create a simplified approval process for gene-edited plants that could have occurred through conventional breeding. The proposal has faced opposition in the European Parliament, where Green and Left groups hold sufficient votes to block it. Franziska Achterberg, a food policy advisor for Greenpeace EU, argued in testimony before the Parliament's Environment Committee in November 2025 that "the absence of foreign DNA does not mean the absence of risk. These are novel organisms entering ecosystems and food chains. Precaution demands rigorous, independent assessment."

Scientists counter that gene editing is more predictable and potentially safer than conventional breeding, which involves random mutations induced by radiation or chemicals—techniques that are not subject to GMO regulations. A 2025 meta-analysis published in the Proceedings of the National Academy of Sciences reviewed 147 studies of gene-edited crops and found no evidence of ecological harm or adverse health effects in feeding trials. The authors noted that conventional mutation breeding has introduced thousands of crop varieties since the 1950s without safety testing, while gene-edited varieties face scrutiny that "bears no relationship to actual risk profiles."

Water Scarcity and the Clock

The urgency of the regulatory debate is shaped by accelerating environmental pressures. Global freshwater availability per capita has declined by 23 percent since 2000, according to the UN Food and Agriculture Organization. By 2040, an estimated 3.9 billion people will live in regions experiencing severe water stress during at least one month per year, up from 2.3 billion in 2020. Agriculture accounts for 70 percent of global freshwater withdrawals, and conventional crop breeding has approached biological limits in improving water-use efficiency.

Dr. Sudha Nair, a plant physiologist at the Indian Council of Agricultural Research, has spent 11 years developing a gene-edited rice variety that maintains yields with 40 percent less water. India's Genetic Engineering Appraisal Committee has been reviewing her application since 2022. "Every monsoon that fails, I think about the farmers who could have planted this rice," she said. India experienced its driest monsoon season in 15 years in 2025, with rice production falling by 18 percent. The country is both the world's largest rice exporter and home to 224 million undernourished people, according to the FAO's State of Food Security and Nutrition in the World 2025 report.

The regulatory paralysis has created a geographic divide in agricultural innovation. Argentina approved 17 gene-edited crop varieties between 2018 and 2025, including drought-tolerant wheat, herbicide-resistant soybeans, and high-oleic safflower. Brazilian farmers planted gene-edited soybeans on 4.2 million hectares in 2025, according to the Brazilian Ministry of Agriculture. In contrast, African nations—where 282 million people face acute food insecurity, per the World Food Programme—have approved only three gene-edited varieties: a disease-resistant banana in Uganda, pest-resistant cowpea in Nigeria, and virus-resistant cassava in Kenya. Ethiopia, Tanzania, and Mozambique maintain effective bans.

The Smallholder Question

Even where gene-edited crops are legal, questions remain about whether smallholder farmers—who produce 35 percent of global food on farms smaller than two hectares—will benefit. Seed companies have focused development on commodity crops for large-scale agriculture: soybeans, maize, and wheat varieties for mechanized farming in the Americas and Australia. Orphan crops that feed millions but generate modest profits—sorghum, millet, teff, yam—have received limited research investment despite their importance to food security in sub-Saharan Africa and South Asia.

The African Orphan Crops Consortium, established in 2011, has sequenced the genomes of 101 indigenous African crops to enable breeding and gene editing. But translating genetic knowledge into seeds that reach farmers requires infrastructure that is largely absent: national research capacity, extension services, and seed distribution systems. Dr. Issoufou Kapran, a crop geneticist at the International Crops Research Institute for the Semi-Arid Tropics in Niger, noted that even when improved varieties are developed, "the challenge is the last mile. A farmer in a village 200 kilometers from the capital does not benefit from a seed that exists only in a research station."

Some initiatives have attempted to bridge this gap. The CGIAR research consortium has committed to making gene-edited varieties available to smallholders through public research institutions and to negotiate royalty-free licenses from patent holders for use in low-income countries. The Gates Foundation has invested $780 million since 2020 in developing and distributing gene-edited crops for smallholder farmers in Africa and South Asia, according to the foundation's 2025 annual report. Critics including the Alliance for Food Sovereignty in Africa have argued that such initiatives reinforce dependency on external technology and undermine investment in agroecological approaches that build soil health and biodiversity.

The Soil Beneath the Debate

The focus on gene-edited crops has overshadowed a parallel crisis that no technology alone can solve: soil degradation. The UN Convention to Combat Desertification reported in 2024 that 40 percent of the world's agricultural land is degraded, with soil organic matter declining at rates of 0.5 to 1 percent annually in intensive farming systems. Degraded soils hold less water, support fewer beneficial microorganisms, and require more chemical inputs to maintain yields. A gene-edited wheat variety that uses water more efficiently cannot compensate for soil that no longer retains moisture.

Dr. Rattan Lal, a soil scientist at Ohio State University who received the World Food Prize in 2020, has argued that agricultural research institutions have systematically underfunded soil science relative to crop genetics. "We can engineer a plant to tolerate drought, but if we have depleted the soil of its capacity to support that plant, we have solved only half the problem," he said in a February 2026 lecture at the World Agricultural Forum in Nairobi. Lal advocates for integrating gene-edited crops with regenerative agricultural practices: cover cropping, reduced tillage, and crop rotation systems that rebuild soil organic matter. Field trials in Kenya and Tanzania combining drought-tolerant maize with agroecological practices showed 67 percent higher yields than gene-edited varieties alone.

What Comes Next

Regulatory decisions expected in 2026 will determine whether gene-edited crops reach the regions where food insecurity is most acute. The European Commission is expected to bring its revised biotechnology regulations to a vote in the European Parliament by September. India's Genetic Engineering Appraisal Committee has 14 applications for gene-edited crops pending, including Dr. Nair's drought-tolerant rice. Kenya's National Biosafety Authority announced in March that it would issue decisions on six pending applications by the end of 2026.

Scientists warn that delays carry compound costs. Each year that high-yielding, climate-resilient varieties remain in research stations rather than farmers' fields represents harvests lost, incomes forgone, and food insecurity deepened. The UN's 2025 State of Food Security and Nutrition in the World report found that the number of people unable to afford a healthy diet increased to 3.1 billion in 2024, up from 2.8 billion in 2020, reversing two decades of progress. Climate change is accelerating: the Intergovernmental Panel on Climate Change's 2025 synthesis report projects that crop yields in water-stressed regions will decline by 15 to 30 percent by 2050 under current emissions trajectories.

Back in Machakos County, Samuel Wanjiru has begun fallowing one of his three hectares—leaving it unplanted to recover—because he cannot afford the inputs for crops that increasingly fail. He has heard that new seed varieties might help, but he does not know when they will arrive, or whether they will be affordable when they do. "The rains are changing," he said. "We need something to change with them."